Chris Stokes

President & General Manager, Eli Lilly and Company UK, Ireland & Northern Europe

Chris Stokes is President and General Manager (GM) of Eli Lilly and Company UK, Ireland & Northern Europe, and was appointed to the role in July 2024. Chris leads Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Oncology, Immunology and Neuroscience.

Chris joined the UK team from his previous role as General Manager at Eli Lilly and Company Korea, where he led the Korean affiliate to strong business results driven by new product growth. His 15-year career at Lilly includes roles as GM of Eli Lilly and Company South Africa and Sub-Saharan Africa, as well as COO of Lilly USA.

Chris has built a reputation for expertise in the global regulatory landscape and an unfaltering commitment to patient access to innovative medicines to enhance health and enrich patient quality of life. He has a “better to best” mindset and brings a focus on delivering results while building and engaging strong teams with high integrity.

Chris holds a Bachelor’s degree from George Mason University and a Master’s in Public Administration from Indiana University-Bloomington.